Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice

Abstract

DCB-only angioplasty, for stable angina and predominantly large vessels, is safe compared to DES as part of routine clinical practice, in terms of all-cause mortality and MACE, including unplanned TLR.